AbbVie Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
AbbVie Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2012 to Q4 2024.
  • AbbVie Inc. Amortization of Intangible Assets for the quarter ending December 31, 2024 was $1.93B, a 1.74% increase year-over-year.
  • AbbVie Inc. Amortization of Intangible Assets for the twelve months ending December 31, 2024 was $7.62B, a 4.08% decline year-over-year.
  • AbbVie Inc. annual Amortization of Intangible Assets for 2024 was $7.62B, a 4.08% decline from 2023.
  • AbbVie Inc. annual Amortization of Intangible Assets for 2023 was $7.95B, a 3.34% increase from 2022.
  • AbbVie Inc. annual Amortization of Intangible Assets for 2022 was $7.69B, a 0.38% decline from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $7.62B $1.93B +$33M +1.74% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-14
Q3 2024 $7.59B $1.9B -$100M -5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $7.69B $1.9B -$200M -9.52% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $7.89B $1.89B -$57M -2.93% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $7.95B $1.9B -$136M -6.69% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-14
Q3 2023 $8.08B $2B $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $8.08B $2.1B +$300M +16.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $7.78B $1.95B +$93M +5.01% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $7.69B $2.03B +$225M +12.4% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-14
Q3 2022 $7.46B $2B +$100M +5.26% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $7.36B $1.8B -$200M -10% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $7.56B $1.86B -$154M -7.67% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $7.72B $1.81B -$52M -2.79% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $7.77B $1.9B -$200M -9.52% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $7.97B $2B +$600M +42.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $7.37B $2.01B +$1.57B +352% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $5.81B $1.86B +$1.47B +376% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $4.34B $2.1B +$1.71B +440% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $2.62B $1.4B +$1.01B +261% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-02
Q1 2020 $1.61B $444M +$59M +15.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $1.55B $391M +$71M +22.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $1.48B $389M +$69M +21.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $1.41B $388M +$64M +19.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $1.35B $385M +$55M +16.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $1.29B $320M +$52M +19.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-19
Q3 2018 $1.24B $320M +$52M +19.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $1.19B $324M +$55M +20.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $1.14B $330M +$59M +21.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q4 2017 $1.08B $268M +$58M +27.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $1.02B $268M +$60M +28.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $958M $269M +$88M +48.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $870M $271M +$106M +64.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $764M $210M +$70M +50% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $694M $208M +$83M +66.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $611M $181M +$95M +110% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $516M $165M +$97M +143% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $419M $140M +$44M +45.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $375M $125M +$27M +27.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $348M $86M -$13M -13.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $361M $68M -$42M -38.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $403M $96M -$5M -4.95% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $408M $98M -$39M -28.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $447M $99M -$37M -27.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $484M $110M -$25M -18.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 $509M $101M -$35M -25.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-19
Q3 2013 $544M $137M +$3M +2.24% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $541M $136M -$40M -22.7% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $581M $135M -$44M -24.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 $625M $136M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-20
Q3 2012 $134M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $176M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $179M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.